AQIA.US AQIA

Technology Software - Application USA Stocks
0.1260 USD
Close of Nov 4, 2026
0.1090 0.1890
Market cap
USD 7.39M
P/E
-
P/B
0.00x
ROE
-3.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is AQIA.US undervalued?

Graham number

The Graham number of AQIA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AQIA fundamental analysis

No fundamental analysis for AQIA yet.

AQIA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AQIA

Aquiva Group Inc., through its subsidiary, Aquiva Medical Inc., engages in the commercialization of AquiForm, a proprietary, versatile topical materials platform based on its novel Hydrogel with inter-Penetration Network Anchor (HiPNA) vehicle for consumer health, wellness, and cosmetics; medical device; and therapeutics and transdermal drug-delivery systems. The company was formerly known as BHPA, INC. and changed its name to Aquiva Group Inc. in May 2025. The company was i…

Full company profile